In all cases the diagnosis of SS was confirmed by the presence of (X;18)(p11.2;q11.2) translocation [13] and the possible prognostic role of IGF-1R, CXCR4 and Ezrin was assessed by correlating protein immunoreactivity with clinical and histological features. This evidence concerns the gene CXCR4 and synovial sarcoma.